Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#COVID-19 Rapid Test Kits Market Forecast: What Value Will The Market Reach By 2030?#_x000D_
The covid-19 rapid test kits market size has seen a sharp reduction in recent years. It will grow from $67.38 billion in 2025. This decline in the historical period stems from various factors, including a lower prevalence of infectious diseases, insufficient expansion of diagnostic laboratory infrastructure, limited public health testing initiatives, and restricted rapid test manufacturing capacity._x000D_
_x000D_
_x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#COVID-19 Rapid Test Kits Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_
The increasing healthcare expenditure is projected to stimulate the growth of the COVID-19 rapid test kits market in the coming years. Healthcare expenditure refers to the total financial outlay on healthcare-related goods and services within a particular healthcare system or economy, encompassing spending on healthcare costs. This expenditure plays a vital role in facilitating the development, accessibility, and availability of COVID-19 rapid test kits. For instance, in June 2025, data from the US-based federal agency, the Centers for Medicare & Medicaid Services (CMS), indicated that National Health Expenditure (NHE) in the US grew by 7.5% to $4.9 trillion in 2023, translating to $14,570 per person, and constituted 17.6% of the Gross Domestic Product (GDP). Hospital expenditures specifically saw a 10.4% rise, reaching $1,519.7 billion in 2023, which was a faster rate compared to the 3.2% growth observed in 2022. Consequently, the escalating healthcare expenditure is a significant factor driving the expansion of the COVID-19 rapid test kits market._x000D_
_x000D_
#COVID-19 Rapid Test Kits Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The covid-19 rapid test kits market covered in this report is segmented – _x000D_
_x000D_
1) By Test Type: RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Other Test Types_x000D_
2) By Specimen Type: Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood, Others_x000D_
3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By RT PCR Test: Conventional RT PCR Tests, Real-Time RT PCR Tests, Automated RT PCR Systems _x000D_
2) By Rapid Antigen Test: Nasal Swab Antigen Tests, Saliva-Based Antigen Tests, Lateral Flow Assays _x000D_
3) By Rapid Antibody Test: IgM Or IgG Rapid Tests, Lateral Flow Serological Tests, Enzyme-Linked Immunosorbent Assay (ELISA) Kits_x000D_
4) By Other Test Types: Combination Tests, Molecular Diagnostic Tests, Home Test Kits_x000D_
_x000D_
#COVID-19 Rapid Test Kits Market Innovation Trends Shaping Future Development#_x000D_
Leading firms in the COVID-19 Rapid Test Kits sector are introducing novel solutions, including Antigen Rapid Test Kits, aimed at achieving quicker and more precise virus identification, thereby aiding in the effective management of infection dissemination. These Antigen Rapid Test Kits identify viral proteins associated with infections such as COVID-19, delivering outcomes in 15-30 minutes using a nasal or throat swab. Although their sensitivity is lower compared to PCR tests, they prove effective for rapid screening across large groups. An example is the launch by Kaneka Corporation, a chemical manufacturing company from Japan, in June 2023, of their product KANEKA Immunochromatography Flu A/B and SARS-CoV-2 Ag. This particular test kit facilitates swift and accurate detection of both COVID-19 and influenza viruses from a single nasal swab specimen, yielding results in approximately ten minutes. Its intuitive design negates the requirement for specialized apparatus, rendering it suitable for both healthcare establishments and personal self-testing applications. Furthermore, the kit’s capacity for simultaneous detection of multiple viruses increases its value in clinical environments, supporting prompt diagnoses and fitting treatment choices._x000D_
_x000D_
#COVID-19 Rapid Test Kits Market Company Landscape And Competitive Strategy#_x000D_
Major companies operating in the covid-19 rapid test kits market are Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Quidel Corporation, DiaSorin S.p.A., Mylab Discovery Solutions, Beijing Jinwofu Bioengineering Technology Company, Zhejiang Orient Gene Biotech Co. Ltd, Transasia Bio Medicals, Vanguard Diagnostics, SD Biosensor, Getein Biotech, Hangzhou Biotest Biotech, Boditech Med Inc, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Vivacheck Lab, Fujirebio, Atomo Diagnostics, Senova, CerTest Biotec, Omega Diagnostics, Abingdon Health, Novacyt Group, BioMaxima S.A, SensDx S.A, OraSure Technologies Inc, Sorrento Therapeutics, Monocent Inc, Aurora Biomed, Hologic, Mesa Biotech, Healgen Scientific Limited Liability Company, NTBIO Diagnostics, Motologic, ACRO Biotech, Cellex Inc, Advagen Biotech Ltd, BioMedomics, CapeBio _x000D_
_x000D_
#View The Full COVID-19 Rapid Test Kits Market Report:#_x000D_
_x000D_
#COVID-19 Rapid Test Kits Market Largest Region: Which Geography Holds The Biggest Share?#_x000D_
North America was the largest region in the COVID-19 rapid test kits market in 2025. Western Europe was the second largest region in the global COVID-19 rapid test kits market share. The regions covered in the covid-19 rapid test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.